Stay updated on Dapagliflozin and Metformin in GDM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.

Latest updates to the Dapagliflozin and Metformin in GDM Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3 (v3.4.3 added, v3.4.2 removed).SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 with no user-visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor platform update with no visible changes to the page content or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded a 'Show glossary' option and the labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' to the page. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' from the page.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision updated to v3.3.4; the previous revision v3.3.3 is replaced.SummaryDifference0.1%

- Check80 days agoChange DetectedThe study locations section now includes Louisiana as a location to indicate where the trial is conducted.SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin and Metformin in GDM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.